| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230323 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
Preliminary findings using a hypofractionated DP-IMRT regimen demonstrated that local control, freedom from distant metastases, and overall survival compared favorably with other series of IMRT and chemotherapy. The highly conformal boost to the tumor bed resulted low rates of severe ototoxicity (Grade 3-4). However, the incidence of in-field brain radiation necrosis indicates that 2.34 Gy per fraction is not safe in this setting.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Richard L. M.D., Nancy M.D., David G. M.D., Michael J. M.D., Margie A. M.S., Dennis H. M.D., Suzanne L. M.D.,